Endoscopic Evaluation in Transplantation Candidates
1 other identifier
observational
300
1 country
1
Brief Summary
In consideration of the limited supply of donor organs, the careful selection of transplant candidates is essential to optimize patient outcome after transplantation. Therefore an extensive evaluation of transplant candidates including among others esophagogastroduodenoscopy (EGD) and colonoscopy has been implemented in our centre. The data regarding the prevalence of upper and lower gastrointestinal (GI) pathology in transplant candidates are contradictory and are based on only a few retrospective studies, which often include only a subgroup of transplant candidates. The goal of this project is a prospective evaluation of the frequency of GI pathologies in transplant candidates with specific focus on the following questions:
- 1.Are there GI-pathologies that occur at a higher prevalence in transplant candidates than described in the general population and is there an increase of GI-pathologies since the introduction of the urgency-based organ allocation leading to sicker transplant candidates?
- 2.What is the influence of endoscopic findings on patient management before transplantation?
- 3.Which risk factors can be identified that predict the presence of GI-lesions?
- 4.Is there a subgroup of patients, in which screening colonoscopy before liver transplantation can not be recommended considering the cost/benefit ratio?
- 5.Is there a correlation of endoscopic findings with outcome after liver transplantation or with gastrointestinal complications during or after transplantation (e.g. gastrointestinal bleeding, perforation or gastrointestinal malignancy)?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2006
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2006
CompletedFirst Submitted
Initial submission to the registry
October 5, 2009
CompletedFirst Posted
Study publicly available on registry
October 6, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedOctober 10, 2011
October 1, 2011
4.8 years
October 5, 2009
October 7, 2011
Conditions
Keywords
Eligibility Criteria
Patients evaluated for Tranplantation at Hannover Medical School
You may qualify if:
- Patients who receive upper and/or lower endoscopy during evaluation for transplantation
You may not qualify if:
- patient already on waiting list
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hannover Medical School
Hanover, 30625, Germany
Related Publications (1)
Weismuller TJ, Bleich F, Negm AA, Schneider A, Lankisch TO, Manns MP, Strassburg CP, Wedemeyer J. Screening colonoscopy in liver transplant candidates: risks and findings. Clin Transplant. 2013 Mar-Apr;27(2):E161-8. doi: 10.1111/ctr.12083. Epub 2013 Feb 6.
PMID: 23383749DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Jochen Wedemeyer, MD
MHH
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. T. Weismüller
Study Record Dates
First Submitted
October 5, 2009
First Posted
October 6, 2009
Study Start
February 1, 2006
Primary Completion
December 1, 2010
Study Completion
December 1, 2010
Last Updated
October 10, 2011
Record last verified: 2011-10